tiprankstipranks
Idexx Laboratories (IDXX)
NASDAQ:IDXX

Idexx Laboratories (IDXX) Stock Price & Analysis

1,903 Followers

IDXX Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$372.50 - $583.39
Previous Close$508.26
Volume412.44K
Average Volume (3M)477.94K
Market Cap
$41.98B
Enterprise Value$42.57B
Total Cash (Recent Filing)$453.93M
Total Debt (Recent Filing)$1.05B
Price to Earnings (P/E)49.2
Beta1.50
Aug 06, 2024
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)10.32
Shares Outstanding82,587,328
10 Day Avg. Volume551,819
30 Day Avg. Volume477,935
Standard Deviation0.10
R-Squared0.49
Alpha0.00014
Financial Highlights & Ratios
Price to Book (P/B)39.73
Price to Sales (P/S)46.56
Price to Cash Flow (P/CF)41.10
P/FCF Ratio45.70
Enterprise Value/Market CapN/A
Enterprise Value/Revenue11.63
Enterprise Value/Gross Profit19.44
Enterprise Value/Ebitda45.34
Forecast
Price Target Upside12.81% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6

Bulls Say, Bears Say

Bulls Say
Product LaunchThe company remains on track for the launch of the InVue Dx analyzer which could begin to contribute in 2025.
ProfitabilityThe higher gross margin more than offset the softer revenue in Q1, showing the company’s ability to manage profitability amid revenue challenges.
Veterinary VisitsAnalysts anticipate veterinary visits to improve as comparisons become easier over the year, supporting a flat visit growth rate for the year.
Bears Say
Clinic Visit TrendsVet clinic visits posted another quarter of year-over-year declines, continuing a nearly two-year negative trend.
Customer EngagementApril vet visits were softer compared to March, indicating a potential ongoing decrease in customer engagement.
Revenue GuidanceIDXX reported slightly lower 1Q24 CAG Dx recurring revenue and reduced its 2024 CAG Dx recurring revenue guidance.
---

Financials

Annual

Ownership Overview

1.54%28.44%47.83%22.19%
47.83% Other Institutional Investors
22.19% Public Companies and Individual Investors

Risk Analysis

Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks

Website Traffic

Sorry, No Data Available
There is no website visitor data available for this stock.
---

IDXX FAQ

What was Idexx Laboratories’s price range in the past 12 months?
Idexx Laboratories lowest stock price was $372.50 and its highest was $583.39 in the past 12 months.
    What is Idexx Laboratories’s market cap?
    Currently, no data Available
    When is Idexx Laboratories’s upcoming earnings report date?
    Idexx Laboratories’s upcoming earnings report date is Aug 06, 2024 which is in 55 days.
      How were Idexx Laboratories’s earnings last quarter?
      Idexx Laboratories released its earnings results on May 01, 2024. The company reported $2.81 earnings per share for the quarter, beating the consensus estimate of $2.712 by $0.098.
        Is Idexx Laboratories overvalued?
        According to Wall Street analysts Idexx Laboratories’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Idexx Laboratories pay dividends?
          Idexx Laboratories does not currently pay dividends.
          What is Idexx Laboratories’s EPS estimate?
          Idexx Laboratories’s EPS estimate is $2.89.
            How many shares outstanding does Idexx Laboratories have?
            Idexx Laboratories has 82,587,326 shares outstanding.
              What happened to Idexx Laboratories’s price movement after its last earnings report?
              Idexx Laboratories reported an EPS of $2.81 in its last earnings report, beating expectations of $2.712. Following the earnings report the stock price went down -5.017%.
                Which hedge fund is a major shareholder of Idexx Laboratories?
                Among the largest hedge funds holding Idexx Laboratories’s share is Spence Asset Management. It holds Idexx Laboratories’s shares valued at 23M.
                  ---

                  Company Description

                  Idexx Laboratories

                  Maine-based IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services for the animal veterinary, livestock and poultry, dairy and water testing markets. It operates through the Companion Animal Group; Water Quality Products; Livestock, Poultry and Dairy; and Other segments.
                  ---

                  IDXX Earnings Call

                  Q1 2024
                  0:00 / 0:00
                  ---

                  IDXX Revenue Breakdown

                  34.93%34.93%32.46%9.41%7.63%15.58%
                  34.93% Reference laboratory diagnostic and consulting services
                  32.46% IDEXX VetLab consumables
                  9.41% Rapid assay products
                  7.63% Veterinary software, services and diagnostic imaging systems
                  15.58% Other
                  tipranks
                  ---

                  IDXX Stock 12 Month Forecast

                  Average Price Target

                  $580.17
                  ▲(12.81% Upside)
                  {"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"428":"$428","601":"$601","471.25":"$471.3","514.5":"$514.5","557.75":"$557.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":600,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n  <span style=\"color:#199ca5\">$600.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":580.17,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n  <span style=\"color:#828080\">$580.17</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":520,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n  <span style=\"color:#912767\">$520.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[428,471.25,514.5,557.75,601],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2023","6":"Dec<br/>2023","9":"Mar<br/>2024","12":"Jun<br/>2024","25":"Jun<br/>2025"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,497.51,505.39384615384614,513.2776923076923,521.1615384615385,529.0453846153846,536.9292307692308,544.8130769230769,552.6969230769231,560.5807692307692,568.4646153846154,576.3484615384615,584.2323076923077,592.1161538461538,{"y":600,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,497.51,503.86846153846153,510.2269230769231,516.5853846153846,522.9438461538462,529.3023076923076,535.6607692307692,542.0192307692307,548.3776923076923,554.7361538461538,561.0946153846154,567.4530769230769,573.8115384615385,{"y":580.17,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,497.51,499.24,500.96999999999997,502.7,504.43,506.15999999999997,507.89,509.62,511.35,513.08,514.81,516.54,518.27,{"y":520,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":450.87,"date":1686268800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":498.01,"date":1688688000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":504.08,"date":1691107200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":511.29,"date":1693526400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":445.98,"date":1696550400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":429.3,"date":1698969600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":482.6,"date":1701388800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":537.36,"date":1704412800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":527.14,"date":1706832000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":576.87,"date":1709251200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":519.54,"date":1712275200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":480.6,"date":1714694400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":497.51,"date":1717718400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Zoetis
                  West Pharmaceutical Services
                  Neogen
                  Charles River Labs

                  Best Analysts Covering IDXX

                  1 Year
                  Erin WrightMorgan Stanley
                  1 Year Success Rate
                  11/17 ratings generated profit
                  65%
                  1 Year Average Return
                  +20.90%
                  reiterated a buy rating 30 days ago
                  Copying Erin Wright's trades and holding each position for 1 Year would result in 64.71% of your transactions generating a profit, with an average return of +20.90% per trade.
                  Popular Stocks
                  ---
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis